New HIV drug combo studied in kids for better virus control

NCT ID NCT02016924

Ongoing Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how safe and effective certain HIV medicines are for children and teens (ages 4 weeks to under 18 years) who already have the virus under control. Participants take a combination of drugs (atazanavir or darunavir boosted with cobicistat, plus emtricitabine/tenofovir alafenamide) to keep the virus suppressed. The goal is to find the right doses and confirm the drugs work well in younger patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired immunodeficiency AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) HIV INFECTIONS

Contacts and locations

Locations

AMBSO Masaka Clinical Research Site

Masaka, Uganda
HIV-NAT

Bangkok, 10330, Thailand
Helios Salud

Buenos Aires, C1141 ACG, Argentina
Hospital General de Agudos Cosme Argerich

Buenos Aires, 1151, Argentina
Imperial College Healthcare NHS Trust

London, W2 1NY, United Kingdom
King Edward VIII Hospital

Durban, 3629, South Africa
MU-JHU Research Collaboration/MU-JHU Care Ltd

Kampala, 256, Uganda
Pediatric Infectious Disease Associates

Long Beach, California, 90806, United States
Perinatal HIV Research Unit

Soweto, 2013, South Africa
Peter Morton Medical Building

Los Angeles, California, 90095, United States
Rahima Clinical Trials, a Division of Wits Health Consortium (Pty) Ltd

Johannesburg, 2093, South Africa
SICRA-TASO Mulago National Referral Hospital

Kampala, Uganda
Siriraj Hospital

Bangkok, 10700, Thailand
Srinagarind Hospital

Khon Kaen, 40002, Thailand
St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States
The Aurum Institute: Pretoria Clinical Research Centre

Pretoria, 87, South Africa
The George Washington University

Washington D.C., District of Columbia, 20010, United States
University of Colorado Denver

Aurora, Colorado, 80045, United States
University of South Florida

Tampa, Florida, 33606, United States
University of Stellenbosch

Cape Town, 7505, South Africa
University of Texas Health Science Center of Houston

Houston, Texas, 77030, United States
University of Zimbabwe Clinical Research Centre

Harare, Zimbabwe
University of the Free State

Bloemfontein, 9300, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.